Bank Of New York Mellon Corp Bridge Bio Pharma, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.17 - $18.55 $3.36 Million - $8.7 Million	468,796 New	468,796 $7.77 Billion
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $2.93 Million - $5.01 Million	435,162 New	435,162 $3.32 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $424,607 - $660,975	53,477 Added 14.21%	429,910 $4.27 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $657,918 - $1.53 Million	-126,280 Reduced 25.12%	376,433 $3.42 Million
Q1 2022 May 11, 2022	BUY	$7.34 - $17.16 $112,801 - $263,714	15,368 Added 3.15%	502,713 $5.1 Million
Q4 2021 Feb 11, 2022	BUY	$11.38 - $53.41 $143,854 - $675,155	12,641 Added 2.66%	487,345 $8.13 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $1.01 Million - $1.39 Million	21,608 Added 4.77%	474,704 $22.2 Million
Q2 2021 Aug 11, 2021	BUY	$46.47 - $63.93 $3.94 Million - $5.42 Million	84,707 Added 22.99%	453,096 $27.6 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $5.36 Million - $6.99 Million	96,607 Added 35.55%	368,389 $22.7 Million
Q4 2020 Feb 09, 2021	BUY	$38.38 - $71.11 $915,209 - $1.7 Million	23,846 Added 9.62%	271,782 $19.3 Million
Q3 2020 Nov 12, 2020	BUY	$27.2 - $42.19 $449,724 - $697,569	16,534 Added 7.15%	247,936 $9.3 Million
Q2 2020 Aug 12, 2020	BUY	$22.22 - $35.69 $154,473 - $248,116	6,952 Added 3.1%	231,402 $7.55 Million
Q1 2020 May 06, 2020	BUY	$16.11 - $36.23 $2.33 Million - $5.25 Million	144,812 Added 181.84%	224,450 $6.51 Million
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $345,999 - $898,326	19,265 Added 31.91%	79,638 $2.79 Million
Q3 2019 Nov 07, 2019	BUY	$20.13 - $32.38 $1.22 Million - $1.95 Million	60,373 New	60,373 $1.3 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$592 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$588 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$333 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$292 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$142 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account